NCT07218809 2026-01-16
TREVI-OC-01
AstraZeneca
Phase 3 Recruiting
Clinical Trials
5 trialsNCT04209855 2025-08-27
MIRASOL
AbbVie
Phase 3 Completed
NCT04296890 2024-08-07
SORAYA
ImmunoGen, Inc.
Phase 3 Completed
NCT05622890 2022-11-21
A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT02631876 2020-10-14
FORWARD I
ImmunoGen, Inc.
Phase 3 Completed